Yu Jiang - Publications

Comment on: "Hepatic immune-related adverse event increased the overall survival of patients with malignancies treated with immune checkpoint inhibitors".

Journal: Hepatology international

Published: April 21, 2025

Comment on the recent gluten challenge study in adults on a gluten‑free diet with unconfirmed coeliac disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 19, 2025

Comment on "Development of nomograms to predict outcomes for large hepatocellular carcinoma after liver resection".

Journal: Hepatology international

Published: April 19, 2025

Letter to the Editor From Yang et al: "Cognitive Risk Stratification Score in Middle-Aged and Older Adults With Type 2 Diabetes: A Cross-Sectional Study".

Journal: The Journal of clinical endocrinology and metabolism

Published: April 14, 2025

Efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis: A systematic review and meta-analysis of randomized controlled trials.

Journal: International immunopharmacology

Published: October 20, 2024

Hirudin promotes cerebral angiogenesis and exerts neuroprotective effects in MCAO/R rats by activating the Wnt/β-catenin pathway.

Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Published: September 04, 2024

Hypoxia-Responsive Covalent Organic Framework Nanoplatform for Breast-Cancer-Targeted Cocktail Immunotherapy via Triple Therapeutic Switch Mechanisms.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: August 26, 2024

Androgen receptor cofactors: A potential role in understanding prostate cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 06, 2024

Rosavin derived from Rhodiola alleviates colitis in mice through modulation of Th17 differentiation.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 25, 2023

Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma.

Journal: Cancer medicine

Published: March 25, 2022

Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer.

Journal: PloS one

Published: February 07, 2021

Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis.

Journal: Cancer gene therapy

Published: November 25, 2017